Search results
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To...
Benzinga via Yahoo Finance· 15 minutes agoOn Wednesday, Pfizer Inc. (NYSE:PFE) reported first-quarter adjusted EPS of $0.82, down 33% year...
Pfizer Reportedly Plans D2C COVID and Migraine Drug Platform
PYMNTS.com· 33 minutes agoPharmaceutical giant Pfizer is reportedly creating an online platform selling anti-COVID and...
Pfizer earnings beat by $0.29, revenue topped estimates
Investing.com· 12 hours agoPfizer earnings beat by $0.29, revenue topped estimates
Pfizer reports dip in first quarter profits, yet beats estimates
dpa international via Yahoo Finance· 1 hour agoThe US pharmaceutical giant Pfizer on Wednesday said its earnings for the first quarter had declined...
Pfizer (PFE) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 3 hours agoWhile the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed...
Pfizer Stock Rises as Outlook Rises After Earnings Beat
Barrons.com· 4 hours agoPfizer bumped up its earnings guidance on Wednesday while reporting better financial results than...
Pfizer (PFE) Q1 Earnings and Revenues Beat Estimates
Zacks via Yahoo Finance· 5 hours agoPfizer (PFE) delivered earnings and revenue surprises of 46.43% and 7.37%, respectively, for the quarter ended March 2024. Do the numbers hold clues to...
Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expect
Guru Focus· 10 hours agoPfizer Inc (PFE, Financial) released its 8-K filing on May 1, 2024, disclosing the financial outcomes for the first quarter of 2024. Pfizer, a leading global ...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid
Reuters via AOL· 6 hours ago(Reuters) -Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 5 hours agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...